Mass Spectrometry‑Based Quantitative Proteomics Using SILAC
- Drug target screening and pathway identification: comparing protein expression changes before and after drug treatment to identify targets and characterize their upstream and downstream effects.
- Studies of signaling pathway activation and dysregulation: capturing time-dependent responses of signaling proteins, such as transcription factors and kinases.
- Analysis of post-transcriptional regulation and nascent protein synthesis: using pulse SILAC to investigate translation rates, mRNA stability, and related processes.
- Dynamic analysis of the cell cycle, differentiation, and stress responses: multi-time-point SILAC designs can systematically reveal the dynamic remodeling of protein networks during cell fate determination.
- Functional exosome and secretome studies: tracking alterations in cellular secretion pathways and identifying potential mediators of intercellular communication or disease biomarkers.
- Customized labeling strategy design supporting both double-labeling and triple-labeling experimental models.
- Stably labeled cell line development services to ensure labeling efficiency >98%.
- High-sensitivity detection based on the Orbitrap Exploris platform, suitable for studies of dynamic protein regulation.
- Multi-dimensional data interpretation services, including differential protein screening, pathway enrichment, and PPI network construction.
- Support for integrated analyses of PTM proteomics, including phosphorylation and ubiquitination, to further extend research depth.
With the advancement of large-scale mass spectrometry, proteomics research has gradually shifted from identification-focused analysis to quantitative analysis. Compared with conventional protein detection methods such as Western blotting or ELISA, mass spectrometry-based quantitative proteomics offers high throughput, high accuracy, and broad proteome coverage. Among the available quantitative strategies, SILAC has been widely applied in cell-based studies because of its high precision, low technical variability, and strong batch-to-batch consistency. By combining metabolic labeling with high-resolution mass spectrometry, SILAC enables relative quantification of samples under different conditions within a single experiment and is particularly well suited for studies of dynamic changes, responses to perturbation, and mechanistic investigation.
Principles and Experimental Workflow of SILAC
SILAC is a stable isotope labeling strategy based on cellular metabolism. In this approach, lysine (Lys) and/or arginine (Arg) labeled with ^13C or ^15N are added to the cell culture medium, allowing cells to incorporate these “heavy” amino acids into newly synthesized proteins during protein biosynthesis. After continuous passaging, the cellular proteome can achieve highly efficient isotope incorporation. The experimental and control groups are cultured separately under “heavy” and “light” amino acid conditions. After the designated treatments, the samples are combined and subjected to protein extraction, enzymatic digestion, liquid chromatography separation, and mass spectrometric analysis. In the mass spectrometer, corresponding peptides with different labeling states exhibit defined mass differences, thereby enabling quantitative comparison of protein abundance between groups.
Core Advantages of SILAC Coupled With Mass Spectrometry for Quantitative Proteomics
1. Endogenous Labeling Improves Quantitative Accuracy
Because labeling occurs during protein biosynthesis, SILAC does not depend on any in vitro derivatization reaction. In addition, differently labeled samples can be combined prior to downstream analytical processing, effectively reducing inter-batch variation. Compared with in vitro labeling strategies such as TMT or iTRAQ, SILAC more accurately reflects changes in protein abundance.
2. High Reproducibility Suitable for Mechanistic Studies
SILAC demonstrates strong quantitative reproducibility across experimental replicates and is particularly suitable for detecting subtle changes in protein expression. Its low technical variability makes it a preferred approach for experiments that require highly stable quantitative data, such as mechanism validation and drug response analysis.
3. Expandable to Multi-Condition and Multi-Time-Point Experimental Designs
By using light, medium, and heavy labeling states, SILAC can be extended to multi-sample comparative designs and adapted for studies involving multiple time points, dose-response conditions, or multiple treatment groups. In addition, pulse SILAC can be used to analyze protein synthesis rates, thereby extending the application of SILAC to studies of post-transcriptional regulation.
4. Strong Compatibility With Post-Translational Modification (PTM) Studies
SILAC-based quantification can be integrated with enrichment strategies for post-translational modifications, such as phosphorylation, acetylation, and ubiquitination. This enables integrated proteomic analyses of protein expression and modification status, thereby supporting mechanistic interpretation from multiple levels.
Application Scenarios
SILAC is suitable for a range of research scenarios involving the regulation of cellular states and functional changes, including:
Key Considerations and Technical Requirements
The reproducibility and reliability of SILAC-based quantitative proteomics depend on several critical technical factors:
1. Cell Compatibility and Labeling Efficiency
Not all cell lines can efficiently incorporate exogenous amino acids, and some may exhibit substantial endogenous synthesis of lysine or arginine. Cell compatibility should therefore be evaluated in advance, and optimization may require the use of dialyzed FBS or other culture adaptations.
2. Passage Number and Labeling Stability
To ensure complete protein labeling, stable culture over at least 5-7 passages is typically required. Labeling efficiency should be verified by pilot experiments or mass spectrometric assessment to establish a reliable basis for downstream data analysis.
3. Support From High-Resolution Mass Spectrometry Platforms
High-resolution mass spectrometry platforms such as Orbitrap Exploris and Q Exactive can accurately resolve light and heavy peptide pairs even when m/z differences are small and are therefore essential for ensuring SILAC data quality.
4. Standardized Data Processing Workflows
Quantitative peak extraction, isotope pair recognition, normalization strategies, and related analytical steps should follow a standardized computational framework to ensure data comparability and reproducibility across different projects.
Solutions From MtoZ Biolabs
MtoZ Biolabs has established a comprehensive SILAC-based quantitative proteomics platform that covers the full workflow from experimental design, cell labeling, and sample preparation to high-resolution mass spectrometric acquisition and in-depth data analysis. Platform advantages include:
SILAC provides a high-precision, low-variability strategy for mass spectrometry-based quantitative proteomics and offers distinct advantages for studying dynamic changes at the cellular level. Its applications in pharmacological mechanism studies, signaling regulation analysis, and functional protein screening have become increasingly mature, making it an important tool in both basic and translational research. Building on a well-established technical platform and extensive project experience, MtoZ Biolabs provides end-to-end SILAC-based quantitative proteomics solutions to help researchers uncover deeper biological insights from protein expression data.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
